Equity Overview
Price & Market Data
Price: $1.32
Daily Change: -$0.175 / 13.26%
Daily Range: $1.32 - $1.52
Market Cap: $19,813,776
Daily Volume: 350,577
Performance Metrics
1 Week: -18.46%
1 Month: -11.93%
3 Months: -11.34%
6 Months: -14.77%
1 Year: -50.15%
YTD: -23.64%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.